Gene · 6358
Papers2,754
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 2,754
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Galectin-3 administration drives remyelination after hypoxic-ischemic induced perinatal white matter injury. | Front Cell Neurosci | 2022 | 36204450 | PubTator, text mining | PubMed |
| Microfibrillar-associated protein 2 is a prognostic marker that correlates with the immune microenvironment in glioma. | Front Genet | 2022 | 36204318 | PubTator, text mining | PubMed |
| Single-cell dissection of remodeled inflammatory ecosystem in primary and metastatic gallbladder carcinoma. | Cell Discov | 2022 | 36198671 | PubTator, text mining | PubMed |
| Development and validation of an ECM-related prognostic signature to predict the immune landscape of human hepatocellular carcinoma. | BMC Cancer | 2022 | 36195857 | PubTator, text mining | PubMed |
| Neurogenesis is disrupted in human hippocampal progenitor cells upon exposure to serum samples from hospitalized COVID-19 patients with neurological symptoms. | Mol Psychiatry | 2022 | 36195636 | PubTator, text mining | PubMed |
| A state-of-the-art review on LSD1 and its inhibitors in breast cancer: Molecular mechanisms and therapeutic significance. | Front Pharmacol | 2022 | 36188536 | PubTator, text mining | PubMed |
| HOXC10 Promotes Metastasis in Colorectal Cancer by Recruiting Myeloid-derived Suppressor Cells. | J Cancer | 2022 | 36186898 | PubTator, text mining | PubMed |
| The DPY30-H3K4me3 Axis-Mediated PD-L1 Expression in Melanoma. | J Inflamm Res | 2022 | 36185638 | PubTator, text mining | PubMed |
| A novel immune-related gene signature predicts the prognosis of hepatocellular carcinoma. | Front Oncol | 2022 | 36185203 | PubTator, text mining | PubMed |
| Using a machine learning model to predict the development of acute kidney injury in patients with heart failure. | Front Cardiovasc Med | 2022 | 36176988 | PubTator, text mining | PubMed |
| TAK1 inhibition increases proliferation and differentiation of chick retinal cells. | Front Cell Dev Biol | 2022 | 36176271 | PubTator, text mining | PubMed |
| Dengue activates mTORC2 signaling to counteract apoptosis and maximize viral replication. | Front Cell Infect Microbiol | 2022 | 36171757 | PubTator, text mining | PubMed |
| A Novel B7-H6-Targeted IgG-Like T Cell-Engaging Antibody for the Treatment of Gastrointestinal Tumors. | Clin Cancer Res | 2022 | 36166004 | PubTator, text mining | PubMed |
| Exploratory genomic analysis of high-grade neuroendocrine neoplasms across diverse primary sites. | Endocr Relat Cancer | 2022 | 36165930 | PubTator, text mining | PubMed |
| Dynamic Changes in the NK-, Neutrophil-, and B-cell Immunophenotypes Relevant in High Metastatic Risk Post Neoadjuvant Chemotherapy-Resistant Early Breast Cancers. | Clin Cancer Res | 2022 | 36161312 | PubTator, text mining | PubMed |
| Asynchronous excitatory neuron development in an isogenic cortical spheroid model of Down syndrome. | Front Neurosci | 2022 | 36161168 | PubTator, text mining | PubMed |
| FOXP family DNA methylation correlates with immune infiltration and prognostic value in NSCLC. | Front Genet | 2022 | 36160018 | PubTator, text mining | PubMed |
| MJDs family members: Potential prognostic targets and immune-associated biomarkers in hepatocellular carcinoma. | Front Genet | 2022 | 36159990 | PubTator, text mining | PubMed |
| Intensifying the search-based optimization of product line architectures with crossover operators. | Empir Softw Eng | 2022 | 36159892 | PubTator, text mining | PubMed |
| Single-Cell Transcriptomics Analysis of the Pathogenesis of Tendon Injury. | Oxid Med Cell Longev | 2022 | 36148412 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6358/papers?page=34